AutoScience Raises $14M to Scale Research Automation
AutoScience obtained $14 million in additional funding for its efforts to transform the world of science. The investment reflects increasing faith in artificial intelligence as a powerful mechanism for accelerating discoveries in sectors including health care, materials science and biotechnology.
AutoScience, a biotech company co-founded by Richard Wiggins and Nicolo De Ruyter de Wildt that focuses on automating complex research processes via its AI-powered platform, attracted this mixed modal of venture capital and strategic investors in its funding round. The company’s goal is to enable scientists and organizations to drive faster, better outcomes by shortening the time expended on testing and evaluation.
Driving a New Era of Automated Research
AutoScience is part of a fresh group of startups using AI to speed up science, and honestly, that’s no small feat. For years, research has crawled along—full of tedious tasks, endless trial and error, and long waits before you see any real breakthroughs.
Now, AutoScience’s platform shakes things up. Their pitch? Instead of creating single-purpose tools that only do data analysis or modelling, they’re building an AI-powered platform that manages the whole research workflow from beginning to end. That full-package deal stands out, especially now, as more companies want a unified solution rather than bouncing between scattered apps and systems.
This isn’t happening in a bubble, either. Across the industry, you see AI making its way into research pipelines. Think about drug discovery or climate modelling—areas drowning in data. Automated tools now help researchers crunch those numbers in months instead of years, which completely changes the game.
More News: Condor Software Raises $24M for Life Sciences Finance Platform
Competitive Growth
AutoScience isn’t the only player in the AI research game, but its push for full end-to-end automation really sets it apart. Where most competitors stick to building tools for specific jobs, like crunching data or modelling, AutoScience wants to handle the entire research process from start to finish. That all-in-one approach matters, especially now that more industries want everything in one place rather than juggling a patchwork of tools.
With this new funding, AutoScience is in a strong spot to grow its footprint and pull in more users. Experts say platforms powered by AI, like what AutoScience is building, aren’t just making research faster—they’re changing how people make breakthrough discoveries. Now, researchers can run experiments around the clock and get instant results. That means bigger leaps forward in less time.
Of course, none of this works unless AutoScience can actually scale its tech and prove it brings real value to users. If the company can slide its platform into existing research workflows without causing headaches, it’s got a shot at widespread adoption.
Landing $14 million does more than just pay the bills. It shows investors are buying into AutoScience’s vision. They’re betting that AI isn’t just a fancy add-on but the heart of where science is headed—and they want AutoScience leading the charge.
